Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mads Brüner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|December 11, 2025
Citrullinated peptides as drug candidates for rheumatoid arthritisAdrian H Bustos, Mads Brüner, Tue Wenzel Kragstrup, et al.
The Lancet. Rheumatology|April 17, 2026
Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthritisAmalie Dyrelund Broksø, Mads Brüner, Bolette Hartmann, et al.
International Immunopharmacology|September 30, 2022
MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2Tue W Kragstrup, Anne Sofie Sørensen, Mads Brüner, et al.
Autoimmunity Reviews|April 19, 2021
Vasculitis therapy refines vasculitis mechanistic classificationChristopher Kirkegaard Torp, Mads Brüner, Kresten Krarup Keller, et al.
Autoimmunity Reviews|December 16, 2020
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatmentMads Brüner, Anders Dige, Anne Gitte Loft, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|December 11, 2025
Citrullinated peptides as drug candidates for rheumatoid arthritisAdrian H Bustos, Mads Brüner, Tue Wenzel Kragstrup, et al.
The Lancet. Rheumatology|April 17, 2026
Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthritisAmalie Dyrelund Broksø, Mads Brüner, Bolette Hartmann, et al.
International Immunopharmacology|September 30, 2022
MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2Tue W Kragstrup, Anne Sofie Sørensen, Mads Brüner, et al.
Autoimmunity Reviews|April 19, 2021
Vasculitis therapy refines vasculitis mechanistic classificationChristopher Kirkegaard Torp, Mads Brüner, Kresten Krarup Keller, et al.
Autoimmunity Reviews|December 16, 2020
Spondylitis-psoriasis-enthesitis-enterocolitis-dactylitis-uveitis-peripheral synovitis (SPEED-UP) treatmentMads Brüner, Anders Dige, Anne Gitte Loft, et al.
Pageof 1